AstraZeneca
AZN
#55
Rank
S$377.84 B
Marketcap
S$243.63
Share price
1.47%
Change (1 day)
39.18%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): S$9.01

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is S$8.99. In 2024 the company made an earnings per share (EPS) of S$5.87 an increase over its 2023 EPS that were of S$4.97.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$9.01
2024S$5.8718.23%
2023S$4.9781.13%
2022S$2.74631.03%
2021S$0.37-88.11%
2020S$3.16136.89%
2019S$1.33-39.41%
2018S$2.20-28.27%
2017S$3.06-14.37%
2016S$3.5824.11%
2015S$2.88127.55%
2014S$1.27-51.96%
2013S$2.64-58.95%
2012S$6.43-32.2%
2011S$9.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.30 25.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.08 1.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.69-81.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.67-48.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$36.50 306.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$3.31-63.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$12.09 34.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$4.60-48.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$4.60-48.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$5.03-44.08%๐Ÿ‡ฌ๐Ÿ‡ง UK